Abstract
The liver is an attractive target tissue for gene therapy. Current techniques which may be useful for in vivo hepatic gene delivery include viral vectors such as retroviruses, adenoviruses and adeno-associated viruses, and non-viral methods including liposome/DNA complexes, peptide/DNA complexes, dendrimer delivery and direct injection of DNA. While, previous studies have suggested that genes cannot be delivered to liver tissue by direct DNA injection, this review focuses on the factors that lead to significant gene expression in liver, as compared to other tissues, after direct injection of plasmid DNA. Several factors are discussed, including injection technique, DNA dose, DNA diluent and enhancement of transfected gene expression by dexamethasone administration. The current limitations and potential uses of direct DNA injection into liver are reviewed. Direct DNA injection is currently a reliable, reproducible and simple alternative for hepatic gene transduction that provides a tool for molecular research and may have future potential for therapeutic gene delivery.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 265-271 |
| Number of pages | 7 |
| Journal | Advanced Drug Delivery Reviews |
| Volume | 17 |
| Issue number | 3 |
| DOIs | |
| State | Published - Dec 5 1995 |
Fingerprint
Keywords
- Dexamethasone
- Erythropoietin
- Gene therapy
- Gene transfer
- Liver
- Luciferase
- Plasmid expression
ASJC Scopus subject areas
- Pharmaceutical Science
Cite this
Hepatic gene expression after direct DNA injection. / Hickman, M. Anne; Malone, Robert W.; Sih, Tracey R.; Akita, Geoffrey Y.; Carlson, Don M.; Powell, Jerry S.
In: Advanced Drug Delivery Reviews, Vol. 17, No. 3, 05.12.1995, p. 265-271.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Hepatic gene expression after direct DNA injection
AU - Hickman, M. Anne
AU - Malone, Robert W.
AU - Sih, Tracey R.
AU - Akita, Geoffrey Y.
AU - Carlson, Don M.
AU - Powell, Jerry S
PY - 1995/12/5
Y1 - 1995/12/5
N2 - The liver is an attractive target tissue for gene therapy. Current techniques which may be useful for in vivo hepatic gene delivery include viral vectors such as retroviruses, adenoviruses and adeno-associated viruses, and non-viral methods including liposome/DNA complexes, peptide/DNA complexes, dendrimer delivery and direct injection of DNA. While, previous studies have suggested that genes cannot be delivered to liver tissue by direct DNA injection, this review focuses on the factors that lead to significant gene expression in liver, as compared to other tissues, after direct injection of plasmid DNA. Several factors are discussed, including injection technique, DNA dose, DNA diluent and enhancement of transfected gene expression by dexamethasone administration. The current limitations and potential uses of direct DNA injection into liver are reviewed. Direct DNA injection is currently a reliable, reproducible and simple alternative for hepatic gene transduction that provides a tool for molecular research and may have future potential for therapeutic gene delivery.
AB - The liver is an attractive target tissue for gene therapy. Current techniques which may be useful for in vivo hepatic gene delivery include viral vectors such as retroviruses, adenoviruses and adeno-associated viruses, and non-viral methods including liposome/DNA complexes, peptide/DNA complexes, dendrimer delivery and direct injection of DNA. While, previous studies have suggested that genes cannot be delivered to liver tissue by direct DNA injection, this review focuses on the factors that lead to significant gene expression in liver, as compared to other tissues, after direct injection of plasmid DNA. Several factors are discussed, including injection technique, DNA dose, DNA diluent and enhancement of transfected gene expression by dexamethasone administration. The current limitations and potential uses of direct DNA injection into liver are reviewed. Direct DNA injection is currently a reliable, reproducible and simple alternative for hepatic gene transduction that provides a tool for molecular research and may have future potential for therapeutic gene delivery.
KW - Dexamethasone
KW - Erythropoietin
KW - Gene therapy
KW - Gene transfer
KW - Liver
KW - Luciferase
KW - Plasmid expression
UR - http://www.scopus.com/inward/record.url?scp=0029637142&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0029637142&partnerID=8YFLogxK
U2 - 10.1016/0169-409X(95)00060-K
DO - 10.1016/0169-409X(95)00060-K
M3 - Article
VL - 17
SP - 265
EP - 271
JO - Advanced Drug Delivery Reviews
JF - Advanced Drug Delivery Reviews
SN - 0169-409X
IS - 3
ER -